NCT03402828View on ClinicalTrials.gov

Body PSOriasis: Long-term Relapse CONTROL

CompletedOBSERVATIONAL
Enrollment

764

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

May 15, 2020

Study Completion Date

May 15, 2020

Conditions
Psoriasis Vulgaris
Interventions
DRUG

Any topical drug treatment

Any treatment strategy used to prevent relapse of psoriasis symptoms

Trial Locations (1)

420012

"The State Autonomous Foundation of Public Health Republic Clinical Dermatovenereological Dispensary of the Republic of Tatarstan", Kazan'

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY